Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

ST483b

Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replaced by ST483c
Price: $185.00 Add to Cart
H&E (ST483bs*): $185.00 Add to Cart

Microarray Panel:Gastric adenocarcinoma tissue microarray, containing 36 cases of stomach adenocarcinoma, 4 stomach papillary adenocarcinoma, plus 8 normal gastric tissue, single core per case
Cores:48
Cases:48
Layout:8 cols × 6 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678 
A Sto Sto Sto Sto Sto Sto Sto Sto  
B Sto Sto Sto Sto Sto Sto Sto Sto  
C Sto Sto Sto Sto Sto Sto Sto Sto  
D Sto Sto Sto Sto Sto Sto Sto Sto  
E Sto Sto Sto Sto Sto Sto Sto Sto  
F Sto Sto Sto Sto Sto Sto Sto Sto Marked point
Legend: Sto - Stomach

- Malignant tumor, - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IV), - Malignant tumor (stage Ib), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 60 Stomach Adenocarcinoma 1 IIIa T3N1M0 Malignant
A2 2 M 64 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A3 3 M 73 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
A4 4 M 87 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A5 5 M 56 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A6 6 M 63 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
A7 7 M 51 Stomach Adenocarcinoma 2 IV T3N3M0 Malignant
A8 8 M 44 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B1 9 M 40 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B2 10 M 63 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
B3 11 M 59 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
B4 12 M 57 Stomach Adenocarcinoma 3 IV T3N3M0 Malignant
B5 13 F 60 Stomach Adenocarcinoma 2–3 IIIa T3N1M0 Malignant
B6 14 M 47 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B7 15 F 72 Stomach Adenocarcinoma 2 IV T4N0M1 Malignant
B8 16 M 32 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
C1 17 M 70 Stomach Adenocarcinoma 2–3 II T3N0M0 Malignant
C2 18 M 55 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
C3 19 F 32 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
C4 20 F 37 Stomach Adenocarcinoma 3 IIIb T3N2M0 Malignant
C5 21 F 33 Stomach Adenocarcinoma 3 IV T4N1M1 Malignant
C6 22 M 55 Stomach Adenocarcinoma 2 IIIa T4N0M0 Malignant
C7 23 M 50 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
C8 24 F 56 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
D1 25 F 39 Stomach Adenocarcinoma 3 IIIb T3N2M0 Malignant
D2 26 M 58 Stomach Adenocarcinoma 3 IIIb T3N2M0 Malignant
D3 27 F 30 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
D4 28 F 41 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
D5 29 M 52 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
D6 30 M 55 Stomach Adenocarcinoma 3 IV T3N3M0 Malignant
D7 31 M 52 Stomach Adenocarcinoma 3 IV T3N3M0 Malignant
D8 32 M 50 Stomach Adenocarcinoma 3 IIIa T3N1M0 Malignant
E1 33 M 44 Stomach Adenocarcinoma 3 IIIb T3N2M0 Malignant
E2 34 M 53 Stomach Adenocarcinoma 3 IIIb T3N2M0 Malignant
E3 35 M 45 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E4 36 M 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
E5 37 M 60 Stomach Papillary adenocarcinoma 2 II T3N0M0 Malignant
E6 38 M 46 Stomach Papillary adenocarcinoma 2 II T3N0M0 Malignant
E7 39 M 62 Stomach Papillary adenocarcinoma 2 II T3N0M0 Malignant
E8 40 M 55 Stomach Papillary adenocarcinoma 2 Ib T2N0M0 Malignant
F1 41 M 49 Stomach Normal gastric tissue – – – Normal
F2 42 M 30 Stomach Normal gastric tissue – – – Normal
F3 43 M 25 Stomach Normal gastric tissue – – – Normal
F4 44 M 35 Stomach Normal gastric tissue – – – Normal
F5 45 M 30 Stomach Normal gastric tissue – – – Normal
F6 46 M 30 Stomach Normal gastric tissue – – – Normal
F7 47 M 31 Stomach Normal gastric tissue – – – Normal
F8 48 M 35 Stomach Normal gastric tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal